Bionomics Ltd. ADR (NASDAQ:BNOX) has a beta value of 0.27 and has seen 1.92 million shares traded in the last trading session. The company, currently valued at $5.60M, closed the last trade at $0.32 per share which meant it gained $0.02 on the day or 6.88% during that session. The BNOX stock price is -400.0% off its 52-week high price of $1.60 and 43.75% above the 52-week low of $0.18. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.79 million shares traded. The 3-month trading volume is 9.52 million shares.
The consensus among analysts is that Bionomics Ltd. ADR (BNOX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ:BNOX) trade information
Sporting 6.88% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BNOX stock price touched $0.32 or saw a rise of 7.19%. Year-to-date, Bionomics Ltd. ADR shares have moved -78.17%, while the 5-day performance has seen it change 7.95%. Over the past 30 days, the shares of Bionomics Ltd. ADR (NASDAQ:BNOX) have changed 10.35%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.13.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 94.67% from current levels. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the current price level is -1775.0% off the targeted high while a plunge would see the stock gain -1775.0% from current levels.
Bionomics Ltd. ADR (BNOX) estimates and forecasts
Figures show that Bionomics Ltd. ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -58.58% over the past 6 months, with this year growth rate of 41.81%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be -100.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 14.53% over the past 5 years.
BNOX Dividends
Bionomics Ltd. ADR is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Bionomics Ltd. ADR (NASDAQ:BNOX)’s Major holders
The top two institutional holders are ARMISTICE CAPITAL, LLC with over 1.23 million shares worth more than $0.94 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 12.9314% of shares outstanding.
The other major institutional holder is LYNX1 CAPITAL MANAGEMENT LP, with the holding of over 0.6 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.46 million and represent 6.3212% of shares outstanding.
